Plain-English translation of NCT07607418 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called as a maintenance therapy — meaning you take it after your initial cancer treatment to help keep the cancer from coming back. The study focuses on patients with specific blood cancers (acute myeloid leukemia or myelodysplastic syndrome) that have a particular genetic mutation, and who are not eligible for a stem cell transplant. The medication works by targeting the genetic change that drives these cancers.
Many patients with these blood cancers cannot have a stem cell transplant due to age, health conditions, or other factors, leaving them with limited options to prevent relapse. This study aims to find an effective and safe maintenance treatment to help keep patients in remission longer and improve their outcomes.
You likely qualify if…
You likely don't qualify if…
You would take the medication by mouth daily for as long as it is helping your cancer stay in remission and you are tolerating it well. You will have regular clinic visits for blood tests and check-ups to monitor how you are doing and watch for any side effects. The study will continue until your cancer progresses, you experience unacceptable side effects, or the study ends.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
China